Check-Cap Surges 233.8% Following Merger Agreement with MBody AI
Deep News
Sep 15
Check-Cap Ltd (CHEK), an Israeli clinical medical diagnostics company, saw its stock price surge 233.8% during Monday's pre-market trading session following the announcement of a merger agreement with MBody AI. Under the terms of the agreement, MBody AI will hold 90% of the combined entity's shares, while Check-Cap will retain a 10% stake. Both companies aim to enter the high-growth artificial intelligence sector through this strategic combination.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.